AAAAAA

   
Results: 1-15 |
Results: 15
INSIGHT INTO THE ORIGIN AND CLONAL HISTORY OF B-CELL TUMORS AS REVEALED BY ANALYSIS OF IMMUNOGLOBULIN VARIABLE REGION GENES
Authors: STEVENSON F SAHOTA S ZHU DL OTTENSMEIER C CHAPMAN C OSCIER D HAMBLIN T
Citation: F. Stevenson et al., INSIGHT INTO THE ORIGIN AND CLONAL HISTORY OF B-CELL TUMORS AS REVEALED BY ANALYSIS OF IMMUNOGLOBULIN VARIABLE REGION GENES, Immunological reviews, 162, 1998, pp. 247-259
PRELIMINARY-RESULTS OF THE UK MEDICAL-RESEARCH-COUNCIL TRIAL IN CHRONIC LYMPHOCYTIC-LEUKEMIA - CLL3
Authors: CATOVSKY D HAMBLIN T RICHARDS S
Citation: D. Catovsky et al., PRELIMINARY-RESULTS OF THE UK MEDICAL-RESEARCH-COUNCIL TRIAL IN CHRONIC LYMPHOCYTIC-LEUKEMIA - CLL3, British Journal of Haematology, 102(1), 1998, pp. 278-278
THE USE OF IMMUNOGLOBULIN HEAVY-CHAIN VARIABLE REGION GENES IN CHRONIC LYMPHOCYTIC-LEUKEMIA
Authors: HAMBLIN T DAVIS Z OSCIER D STEVENSON F
Citation: T. Hamblin et al., THE USE OF IMMUNOGLOBULIN HEAVY-CHAIN VARIABLE REGION GENES IN CHRONIC LYMPHOCYTIC-LEUKEMIA, British Journal of Haematology, 101, 1998, pp. 89-89
A PILOT-STUDY OF IDIOTYPIC VACCINATION FOR FOLLICULAR B-CELL LYMPHOMAUSING A GENETIC APPROACH
Authors: HAWKINS RE RUSSELL SJ MARCUS R ASHWORTH LJ BRISSNIK J ZHANG J WINTER G BLEEHEN NM STEVENSON F HAMBLIN T OSCIER D ZHU DL KING C KUMAR S THOMPSETT A STEVENSON GT
Citation: Re. Hawkins et al., A PILOT-STUDY OF IDIOTYPIC VACCINATION FOR FOLLICULAR B-CELL LYMPHOMAUSING A GENETIC APPROACH, Human gene therapy, 8(10), 1997, pp. 1287-1299
CYTOKINES TO REPLACE PLATELET TRANSFUSIONS
Authors: HAMBLIN T
Citation: T. Hamblin, CYTOKINES TO REPLACE PLATELET TRANSFUSIONS, Transfusion science, 18(1), 1997, pp. 119-119
CYTOKINES TO REDUCE PLATELET TRANSFUSIONS - NON-TPO CYTOKINES
Authors: HAMBLIN T
Citation: T. Hamblin, CYTOKINES TO REDUCE PLATELET TRANSFUSIONS - NON-TPO CYTOKINES, Transfusion science, 18(1), 1997, pp. 121-128
APPLICATION OF THE INTERNATIONAL SCORING SYSTEM FOR MYELODYSPLASIA TOM.D.-ANDERSON PATIENTS - RESPONSE
Authors: GREENBERG P LEBEAU MM FENAUX P MOREL P SANZ G SANZ M VALLESPI T HAMBLIN T OSCIER D OHYASHIKI K TOYAMA K AUL C MUFTI G COX C BENNETT J
Citation: P. Greenberg et al., APPLICATION OF THE INTERNATIONAL SCORING SYSTEM FOR MYELODYSPLASIA TOM.D.-ANDERSON PATIENTS - RESPONSE, Blood, 90(7), 1997, pp. 2844-2846
INTERNATIONAL SCORING SYSTEM FOR EVALUATING PROGNOSIS IN MYELODYSPLASTIC SYNDROMES
Authors: GREENBERG P COX C LEBEAU MM FENAUX P MOREL P SANZ G SANZ M VALLESPI T HAMBLIN T OSCIER D OHYASHIKI K TOYAMA K AUL C MUFTI G BENNETT J
Citation: P. Greenberg et al., INTERNATIONAL SCORING SYSTEM FOR EVALUATING PROGNOSIS IN MYELODYSPLASTIC SYNDROMES, Blood, 89(6), 1997, pp. 2079-2088
MULTICENTER PROSPECTIVE RANDOMIZED TRIAL OF FLUDARABINE VERSUS CYCLOPHOSPHAMIDE, DOXORUBICIN, AND PREDNISONE (CAP) FOR TREATMENT OF ADVANCED-STAGE CHRONIC LYMPHOCYTIC-LEUKEMIA
Authors: FENAUX P BINET JL LEPORRIER M TRAVADE P PIGUET H LINASSIER C DESABLENS B DREYFUS B BRIZARD CP MURGUE B RUSSET T SOUTEYRAND P JOHNSON S PHILLIPS MJ HIDDEMANN W SMITH A ROATH S LOFFLER H BJORKHOLM M OSBY E EMMERICH B COIFFIER B THIEL E KNAUF W JULIUSSON G MARCUS R PRENTICE AG COPPLESTONE JA FREUND M MILLIGAN PW WINFIELD D YIN J HELLRIEGEL KP HOSSFELD DK KIMBY E BURNETT AK LISTER TA LUCIE N KANZ L LERNER R LINDEMALM C CHILD A HAMBLIN T OSCIER D SMITH JG SINGER RJ PARKER A WHITTAKER J WYLD P SMITH AG
Citation: P. Fenaux et al., MULTICENTER PROSPECTIVE RANDOMIZED TRIAL OF FLUDARABINE VERSUS CYCLOPHOSPHAMIDE, DOXORUBICIN, AND PREDNISONE (CAP) FOR TREATMENT OF ADVANCED-STAGE CHRONIC LYMPHOCYTIC-LEUKEMIA, Lancet, 347(9013), 1996, pp. 1432-1438
TRISOMY-12 DEFINES A GROUP OF CLL WITH ATYPICAL MORPHOLOGY - CORRELATION BETWEEN CYTOGENETIC, CLINICAL AND LABORATORY FEATURES IN 544 PATIENTS
Authors: MATUTES E OSCIER D GARCIAMARCO J ELLIS T COPPLESTONE A GILLINGHAM R HAMBLIN T LENS D SWANSBURY GJ CATOVSKY D
Citation: E. Matutes et al., TRISOMY-12 DEFINES A GROUP OF CLL WITH ATYPICAL MORPHOLOGY - CORRELATION BETWEEN CYTOGENETIC, CLINICAL AND LABORATORY FEATURES IN 544 PATIENTS, British Journal of Haematology, 92(2), 1996, pp. 382-388
INTERNATIONAL WORKSHOP CONSENSUS RISK ANALYSIS SYSTEM FOR MYELODYSPLASTIC SYNDROMES (MDS)
Authors: GREENBERG P FENAUX P MOREL P SANZ G SANZ M VALLESPI T HAMBLIN T OSCIER D OHYASHIKI K TOYAMA K AUL C MUFTI G BENNETT J COX C LEBEAU M
Citation: P. Greenberg et al., INTERNATIONAL WORKSHOP CONSENSUS RISK ANALYSIS SYSTEM FOR MYELODYSPLASTIC SYNDROMES (MDS), Blood, 86(10), 1995, pp. 1065-1065
ASSESSMENT OF THE ROLE OF CLONOGENIC B-LYMPHOCYTES IN THE PATHOGENESIS OF MULTIPLE-MYELOMA
Authors: SAHOTA S HAMBLIN T OSCIER DG STEVENSON FK
Citation: S. Sahota et al., ASSESSMENT OF THE ROLE OF CLONOGENIC B-LYMPHOCYTES IN THE PATHOGENESIS OF MULTIPLE-MYELOMA, Leukemia, 8(8), 1994, pp. 1285-1289
LONG-TERM SURVIVAL ASSOCIATED WITH METASTATIC SMALL-CELL CARCINOMA OFTHE ESOPHAGUS TREATED BY CHEMOTHERAPY, AUTOLOGOUS BONE-MARROW TRANSPLANTATION, AND ADJUVANT RADIATION-THERAPY
Authors: MCCULLEN M VYAS SK WINWOOD PJ LOEHRY CA PARHAM DM HAMBLIN T
Citation: M. Mccullen et al., LONG-TERM SURVIVAL ASSOCIATED WITH METASTATIC SMALL-CELL CARCINOMA OFTHE ESOPHAGUS TREATED BY CHEMOTHERAPY, AUTOLOGOUS BONE-MARROW TRANSPLANTATION, AND ADJUVANT RADIATION-THERAPY, Cancer, 73(1), 1994, pp. 1-4
TRISOMY-12 DEFINES A SUBGROUP OF CLL WITH DISTINCT MORPHOLOGY
Authors: MATUTES E OSCIER D GARCIAMARCO J ELLIS J CHAPMAN R GILLINGHAM R HAMBLIN T CATOVSKY D
Citation: E. Matutes et al., TRISOMY-12 DEFINES A SUBGROUP OF CLL WITH DISTINCT MORPHOLOGY, Blood, 84(10), 1994, pp. 10000656-10000656
THE THERAPEUTIC POTENTIAL AND PROBLEMS OF INTERLEUKIN-2
Authors: HAMBLIN T
Citation: T. Hamblin, THE THERAPEUTIC POTENTIAL AND PROBLEMS OF INTERLEUKIN-2, Chemistry and Industry, (17), 1993, pp. 663-665
Risultati: 1-15 |